Blastocyst Transfer Outcomes in Assisted Reproductive Technologies

Blastocyst transfer has become a cornerstone of in vitro fertilisation strategies, offering a balance between implantation efficiency and minimising the transfer of multiple embryos. Culturing embryos to the blastocyst stage permits selection based on morphological and developmental criteria, which correlate strongly with implantation potential and live birth rates. Day 5 blastocysts typically exhibit higher live birth rates than those reaching the blastocyst stage on day 6 or later, reflecting intrinsic developmental competence. Advances in cryopreservation, particularly vitrification, have enabled the widespread adoption of frozen-thawed blastocyst transfer, often resulting in comparable or improved outcomes relative to fresh transfers by allowing endometrial synchronisation and reducing ovarian stimulation effects.

Recent research has refined our understanding of how blastocyst grade—encompassing expansion, inner cell mass and trophectoderm quality—influences success rates across fresh and frozen cycles. Similarly, the integration of preimplantation genetic testing for aneuploidy has clarified the relationship between chromosomal normality and implantation potential. Taken together, these developments provide clinicians with evidence-based criteria for selecting the most viable blastocyst, optimising live birth rates and reducing the incidence of miscarriage and multiple gestations. As global demand for assisted reproductive technologies grows, these insights offer practical routes to improve patient outcomes and inform personalised transfer protocols.

Research from Nature Portfolio

Recent studies have examined the impact of blastocyst developmental timing and morphology on live birth probability following genetic screening. In a large retrospective analysis of single-embryo transfers of euploid and low-level mosaic blastocysts monitored by time-lapse imaging, day 5 embryos were associated with a significantly higher live birth rate than day 6 embryos. Morphological grading of trophectoderm and inner cell mass emerged as independent predictors of outcome, with high-grade trophectoderm conferring a two- to threefold advantage. These findings emphasise that, even among euploid blastocysts, both the pace of development to the blastocyst stage and quality of the cellular compartments remain key determinants of implantation success.

Blastocyst Transfer Outcomes in Assisted Reproductive Technologies publication trend

The graph below shows the total number of articles in blastocyst transfer outcomes in assisted reproductive technologies across all publications each year (not limited to Nature Index journals).

Technical terms

Blastocyst: An embryo at approximately five to six days post-fertilisation, comprising a fluid-filled cavity, inner cell mass and surrounding trophectoderm.

Trophectoderm (TE): The outer cell layer of a blastocyst that later contributes to placental structures; graded by cellular cohesion and thickness.

Inner cell mass (ICM): A cluster of cells within the blastocyst that gives rise to the foetus; assessed for compactness and cell number.

Vitrification: A rapid freezing technique that prevents ice crystal formation, improving post-thaw embryo viability.

Euploidy: The condition of possessing the correct number of chromosomes, determined via preimplantation genetic testing for aneuploidy (PGT-A).

References

1. Fresh or frozen day 6 blastocyst transfer: is there still a question?. Reproductive Biology and Endocrinology (2024).
2. Live birth rate following frozen-thawed blastocyst transfer is higher in high-grade day 6 blastocysts than in low-grade day 5 blastocysts. Frontiers in Endocrinology (2023).
3. Comparison of clinical outcomes of frozen-thawed D5 and D6 blastocysts undergoing preimplantation genetic testing. Journal of Translational Medicine (2022).